INVESTORS & MEDIA
Corporate Governance
| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Dec 18, 2015 |
SVP Strategy Investor Relation
Trans History: 164
|
SVP Strategy Investor Relation | Form 4 | Other acquisition or disposition | -- | -- | 407 |
| Dec 18, 2015 |
VP Controller and Asst Treasur
Trans History: 372
|
VP Controller and Asst Treasur | Form 4 | Other acquisition or disposition | -- | -- | 4,129 |
| Dec 18, 2015 |
SVP Clinical Development & Reg
Trans History: 208
|
SVP Clinical Development & Reg | Form 4 | Other acquisition or disposition | -- | -- | 12,890 |
| Dec 18, 2015 |
SVP Clinical Development & Reg
Trans History: 208
|
SVP Clinical Development & Reg | Form 4 | Other acquisition or disposition | -- | -- | 1,652 |
| Dec 18, 2015 |
EVP Research and Development
Trans History: 660
|
EVP Research and Development | Form 4 | Other acquisition or disposition | -- | -- | 14,376 |
| Dec 18, 2015 |
EVP Research and Development
Trans History: 660
|
EVP Research and Development | Form 4 | Other acquisition or disposition | -- | -- | 5,599 |
| Dec 18, 2015 |
EVP Research and Development
Trans History: 660
|
EVP Research and Development | Form 4 | Other acquisition or disposition | -- | -- | 6,356 |
| Dec 18, 2015 |
SVP & General Mgr Industrial O
Trans History: 359
|
SVP & General Mgr Industrial O | Form 4 | Other acquisition or disposition | -- | -- | 18,705 |
| Dec 18, 2015 |
SVP & General Mgr Industrial O
Trans History: 359
|
SVP & General Mgr Industrial O | Form 4 | Other acquisition or disposition | -- | -- | 1,426 |
| Dec 18, 2015 |
Director, President Regeneron Laboratori
Trans History: 628
|
Director, President Regeneron Laboratori | Form 4 | Other acquisition or disposition | -- | -- | 5,654 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.